Innoviva, Inc. (INVA)
23.05
-0.36
(-1.54%)
USD |
NASDAQ |
Feb 24, 11:32
Innoviva Price : 23.05 for Feb. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 124.11 |
| Nektar Therapeutics | 71.34 |
| Regeneron Pharmaceuticals, Inc. | 778.05 |
| Oramed Pharmaceuticals, Inc. | 3.35 |
| Theravance Biopharma, Inc. | 19.43 |
Price Related Metrics
| PE Ratio | 16.54 |
| PS Ratio | 4.531 |
| PEG Ratio | 0.1611 |
| Price to Book Value | 1.706 |
| Price to Free Cash Flow | 9.275 |
| Earnings Yield | 6.05% |
| Market Cap | 1.723B |
| PEGY Ratio | 0.1611 |
| Operating PE Ratio | 10.86 |
| Normalized PE Ratio | 13.38 |